Music journalist Ian Cohen and writer/rapper Rollie Pemberton (a.k.a. Cadence Weapon) discuss Ye's latest extreme publicity stunts.

Welcome to the live updates platform for Hindustan Times. Follow the major news updates, headlines and breaking news stories ...

Kanye West is currently selling T-shirts with swastikas on his website, capping off a wild, hate-filled week for the rapper ...

How to increase hunter opportunity and satisfaction during the spring wild turkey season will be the focus of four public discussion meetings – including one in New Ulm – in late September and ...

Kanye West’s Yeezy label has released a collaborative capsule ... The collection’s pieces consist of 5 colors of T-shirts featuring “Sean John” scrawled across their fronts. The Yeezy website also has ...

The rapper famously lost a series of brand deals in 2022 after his first anti-Semitic tirade, with GAP ripping Kanye merchandise from their stores, Universal dropping him and Adidas terminating ...

FOX News may earn a commission if you buy through our referral links. This content was created by a team that works independently from the FOX newsroom. The Super Bowl, one of the biggest sporting ...

The rapper famously lost a series of brand deals in 2022 after his first anti-Semitic tirade, with GAP ripping Kanye merchandise from their stores, Universal dropping him and Adidas terminating ...

Kanye West, professionally known as Ye, recently took to social media to call for fellow rapper Sean "Diddy" Combs' freedom after the latter was arrested on s*x trafficking and prostitution ...

In his most recent rant, Kanye West asked President Donald Trump to free Diddy from jail and the pair also announced a merchandise line. Kanye West has been on an hours-long rant that mentions his ...

Joshua Zirkzee equalized in the 68th minute and Maguire grabbed the late winner. There was a heated debate over whether the England center half was in an offside position but there is no VAR in ...

All nine late-stage kid­ney can­cer pa­tients in a Phase 1 tri­al of a per­son­al­ized vac­cine re­mained can­cer-free af­ter about three years of re­ceiv­ing treat­ment, re­searchers ...